首页 | 本学科首页   官方微博 | 高级检索  
     

新四联方案补救治疗幽门螺杆菌感染临床观察
引用本文:王建刚,吴清明,龙辉,张金华,刘群. 新四联方案补救治疗幽门螺杆菌感染临床观察[J]. 中国药师, 2009, 12(5): 630-631
作者姓名:王建刚  吴清明  龙辉  张金华  刘群
作者单位:武汉科技大学附属天佑医院,武汉,430064
摘    要:目的:探讨含左氧氟沙星的新四联方案补救治疗幽门螺杆菌(坳)感染的疗效及安全性。方法:84例Hp感染初次三联疗法根除失败的消化性溃疡或慢性胃炎患者随机分成两组,治疗组44例,用左氧氟沙星0.2g,阿莫西林1.0g,枸橼酸铋钾0.22g,埃索美拉唑20mg po,bid,连服10d。对照组40例,用四环素1.0g,呋喃唑酮0.2g,胶体果胶铋0.24g,埃索美拉唑20mg po,bid,连服10d。4周后复查14^C—UBT。结果:治疗组和对照组补救治疗Hp感染的根除率分别为88.6%和62.5%(P〈0.01),不良反应发生率为6.8%和33%,差异均有统计学意义(P〈0.01)。结论:新四联方案为安全有效的抗Hp的补救治疗方案。

关 键 词:左氧氟沙星  幽门螺杆菌  根除  补救治疗

Clinincal Study of New Quadruple Regimen as Remedial Therapy on Helicobacter Pylori Infection
Wang Jiangang,Wu Qingming,Long Hui,Zhang Jinhuan,Liu Qun. Clinincal Study of New Quadruple Regimen as Remedial Therapy on Helicobacter Pylori Infection[J]. China Pharmacist, 2009, 12(5): 630-631
Authors:Wang Jiangang  Wu Qingming  Long Hui  Zhang Jinhuan  Liu Qun
Affiliation:(Affiliated Tian You hospital, Wuhan University of science and technology, Wuhan 430064, China)
Abstract:Objective: To explore the effect and safety of contained levofloxacin quadruple regimen on treatment of helicobacter pylori(Hp) infection. Method: Eighty-four peptic ulcer or chronic gastritis patients with a previous failed course of triple therapy were divided into two groups: test group (44patients) were given the new quadruple therapy:levofloxacin 0.2g bid, amoxicillin 1.0g bid plus potassimcitrate bismuth 0.22 g bid and esomeprazole 20mg bid; compare group (40patients) treated with tetracycline. 1.0g bid, furazolidon 0.2 bid,colloidal bismuth pectin (CBS) 0.24g bid, esomeprazole 20mg bid . The course of treatment was 10 days. After 4 weeks,Hp status was assessed by 14^C-UBT. Result: Eradication rates of Hp in the test group were 88.6% and in the compare group were 62.5% ;The side effect rate were 6.8% and 33% respectively. There were statistical difference between two groups( P 〈 0.01 ). Conclusion: Levofloxaein based quadruple regimen is an effective and safe remedial therapy after a failed first line triple therapy.
Keywords:Levofloxacin  Helicobacter pylori  Eradication  Remedial therapy
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国药师》浏览原始摘要信息
点击此处可从《中国药师》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号